Rankings
▼
Calendar
ORIC FY 2020 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
ORIC
ORIC Pharmaceuticals, Inc.
$1B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$74M
Net Income
-$74M
EPS (Diluted)
$-3.36
Cash Flow
Operating Cash Flow
-$45M
Free Cash Flow
-$46M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$299M
Total Liabilities
$9M
Stockholders' Equity
$290M
Cash & Equivalents
$78M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$1M
+100.0%
Operating Income
-$74M
-$29M
-159.7%
Net Income
-$74M
-$27M
-174.2%
← Q4 2019
All Quarters
Q1 2020 →